Barriers to HIV Cure.

Autor: Stein, J.¹ hendrik.streeck@uk-essen.de, Storcksdieck genannt Bonsmann, M.¹, Streeck, H.^1,2

Publikováno v: HLA: Immune Response Genetics. Oct2016, Vol. 88 Issue 4, p155-163. 9p.

Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine.

Autor: Lapuente D; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Stab V; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany., Storcksdieck Genannt Bonsmann M; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany., Maaske A; Environmental Medicine, UNIKA-T Augsburg, Technische Universität München and Helmholtz Zentrum, Neuherberg, Germany., Köster M; Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research, Braunschweig, Germany., Xiao H; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Ehrhardt C; Section of Experimental Virology, Institute of Medical Microbiology, University Hospital Jena, Jena, Germany., Tenbusch M; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Publikováno v: PloS one [PLoS One] 2020 Apr 03; Vol. 15 (4), pp. e0231138. Date of Electronic Publication: 2020 Apr 03 (Print Publication: 2020).

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination.

Autor: Heß R; Department of Molecular and Medical Virology, Ruhr-University Bochum, 44801 Bochum, Germany. rebecca.hess@rub.de., Storcksdieck Genannt Bonsmann M; Department of Molecular and Medical Virology, Ruhr-University Bochum, 44801 Bochum, Germany. michael.storcksdieckgenanntbonsmann@rub.de., Lapuente D; Department of Molecular and Medical Virology, Ruhr-University Bochum, 44801 Bochum, Germany. Dennis.Lapuente@uk-erlangen.de.; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany; Medical Immunology Campus Erlangen, FAU Erlangen-Nürnberg, 91054 Erlangen, Germany. Dennis.Lapuente@uk-erlangen.de., Maaske A; Department of Molecular and Medical Virology, Ruhr-University Bochum, 44801 Bochum, Germany. Andre.Maaske@ruhr-uni-bochum.de., Kirschning C; Institute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Carsten.Kirschning@uk-essen.de., Ruland J; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany. j.ruland@tum.de., Lepenies B; Immunology Unit & Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo) Hannover, 30559 Hannover, Germany. Bernd.Lepenies@tiho-hannover.de., Hannaman D; Ichor Medical Systems, Inc., San Diego, CA 92121, USA. dhannaman@ichorms.com., Tenbusch M; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany; Medical Immunology Campus Erlangen, FAU Erlangen-Nürnberg, 91054 Erlangen, Germany. matthias.tenbusch@fau.de., Überla K; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany; Medical Immunology Campus Erlangen, FAU Erlangen-Nürnberg, 91054 Erlangen, Germany. matthias.tenbusch@fau.de.

Publikováno v: Viruses [Viruses] 2019 Feb 13; Vol. 11 (2). Date of Electronic Publication: 2019 Feb 13.

The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.

Autor: Storcksdieck genannt Bonsmann M; Department of Molecular and Medical Virology, Ruhr-University Bochum, Germany., Niezold T; Department of Molecular and Medical Virology, Ruhr-University Bochum, Germany., Hannaman D; Ichor Medical Systems, Inc., San Diego, CA, USA., Überla K; Department of Molecular and Medical Virology, Ruhr-University Bochum, Germany; Universitätsklinikum Erlangen, Institute of Clinical and Molecular Virology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Tenbusch M; Department of Molecular and Medical Virology, Ruhr-University Bochum, Germany. Electronic address: Matthias.tenbusch@rub.de.

Publikováno v: Vaccine [Vaccine] 2016 Apr 04; Vol. 34 (15), pp. 1744-51. Date of Electronic Publication: 2016 Mar 03.

Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells.

Autor: Storcksdieck genannt Bonsmann M; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum 44801, Germany;, Niezold T; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum 44801, Germany;, Temchura V; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum 44801, Germany; Universitätsklinikum Erlangen, Institut für Klinische und Molekulare Virologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany;, Pissani F; U.S. Military HIV Research Program, Silver Spring, MD 20910;, Ehrhardt K; Department of Medical Microbiology and Hygiene, Institute of Virology, University Medical Center Freiburg, Freiburg 79106, Germany;, Brown EP; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755; and., Osei-Owusu NY; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755; and., Hannaman D; Ichor Medical Systems, Inc., San Diego, CA 92121., Hengel H; Department of Medical Microbiology and Hygiene, Institute of Virology, University Medical Center Freiburg, Freiburg 79106, Germany;, Ackerman ME; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755; and., Streeck H; U.S. Military HIV Research Program, Silver Spring, MD 20910;, Nabi G; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum 44801, Germany;, Tenbusch M; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum 44801, Germany;, Überla K; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum 44801, Germany; Universitätsklinikum Erlangen, Institut für Klinische und Molekulare Virologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany; klaus.ueberla@fau.de.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Nov 15; Vol. 195 (10), pp. 4861-72. Date of Electronic Publication: 2015 Oct 14.